Intravenous IgG: A New Therapeutic Tool

Overview

Journal Can Fam Physician

Specialties General Medicine
Public Health

Date 2011 Jan 22

PMID 21253124

Authors

L K Boshkov

J G Kelton

Affiliations

Soon will be listed here.

Abstract

Since the 1950s, intramuscular gammaglobulin preparations have been used for antibody replacement in patients with immune deficiency syndromes. The authors of this article discuss newer intravenous formulations which have expanded the role of IgG preparations from simple antibody replacement to therapeutic use in high doses as an immune suppressant and an autoimmune modulator.

References

Bjorkander J, Cunningham-Rundles C, Lundin P, Olsson R, Soderstrom R, Hanson L . Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency. Am J Med. 1988; 84(1):107-11. DOI: 10.1016/0002-9343(88)90016-2. View

Sultan Y, Kazatchkine M, Maisonneuve P, Nydegger U . Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984; 2(8406):765-8. DOI: 10.1016/s0140-6736(84)90701-3. View

Ochs H, Fischer S, Wedgwood R, Wara D, Cowan M, Ammann A . Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med. 1984; 76(3A):78-82. DOI: 10.1016/0002-9343(84)90324-3. View

Imbach P, BARANDUN S, DApuzzo V, Baumgartner C, Hirt A, Morell A . High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981; 1(8232):1228-31. DOI: 10.1016/s0140-6736(81)92400-4. View

Laurian Y, Le Bras P, Ellrodt A, Alvin P . Immune thrombocytopenia gammaglobulin, and positivity to the human T-lymphotropic virus type III. Ann Intern Med. 1986; 105(1):145-6. DOI: 10.7326/0003-4819-105-1-145_3. View

Ordi J, Vilardell M, Alijotas J, Barquinero J, Vila M . Serum thrombocytopenia and high-dose immunoglobulin treatment. Ann Intern Med. 1986; 104(2):282-3. DOI: 10.7326/0003-4819-104-2-282_2. View

Stiehm E, Ashida E, Kim K, Winston D, Haas A, Gale R . Intravenous immunoglobulins as therapeutic agents. Ann Intern Med. 1987; 107(3):367-82. DOI: 10.7326/0003-4819-107-2-367. View

Long A, Denburg J, DENT P . Hypogammaglobulinemia: therapeutic rationale. CMAJ. 1987; 137(9):793-7. PMC: 1267348. View

Leahy M . Subcutaneous immunoglobulin home treatment in hypogammaglobulinaemia. Lancet. 1986; 2(8497):48. DOI: 10.1016/s0140-6736(86)92595-x. View

10.

VON MURALT G, Sidiropoulos D . Experience with intravenous immunoglobulin treatment in neonates and pregnant women. Vox Sang. 1986; 51 Suppl 2:22-9. DOI: 10.1111/j.1423-0410.1986.tb02003.x. View

11.

Copelan E, Strohm P, Kennedy M, Tutschka P . Hemolysis following intravenous immune globulin therapy. Transfusion. 1986; 26(5):410-2. DOI: 10.1046/j.1537-2995.1986.26587020113.x. View

12.

Cross A, Alving B, Sadoff J, Baldwin P, Terebelo H, Tang D . Intravenous immune globulin: a cautionary note. Lancet. 1984; 1(8382):912. DOI: 10.1016/s0140-6736(84)91376-x. View

13.

Karpatkin S . Autoimmune thrombocytopenic purpura. Semin Hematol. 1985; 22(4):260-88. View

14.

Kelton J . Advances in the diagnosis and management of ITP. Hosp Pract (Off Ed). 1985; 20(6):95-99, 102-7. DOI: 10.1080/21548331.1985.11703075. View

15.

Bussel J . Intravenous immune serum globulin in immune thrombocytopenia: clinical results and biochemical evaluation. Vox Sang. 1985; 49 Suppl 1:44-50. DOI: 10.1111/j.1423-0410.1985.tb01143.x. View

16.

DERBY B, ROGERS D . Studies on bacteriemia. V. The effect of simultaneous leukopenia and reticuloendothelial blockade on the early blood stream clearance of staphylococci and Escherichia coli. J Exp Med. 1961; 113:1053-66. PMC: 2137435. DOI: 10.1084/jem.113.6.1053. View

17.

Rousell R, GOOD R, PIROFSKY B, Schiff R . Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communication. Vox Sang. 1988; 54(1):6-13. DOI: 10.1111/j.1423-0410.1988.tb01605.x. View

18.

Woodruff R, Grigg A, Firkin F, Smith I . Fatal thrombotic events during treatment of autoimmune thrombocytopenia with intravenous immunoglobulin in elderly patients. Lancet. 1986; 2(8500):217-8. DOI: 10.1016/s0140-6736(86)92511-0. View

19.

Bussel J, Hilgartner M . Intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura in childhood and adolescence. Hematol Oncol Clin North Am. 1987; 1(3):465-82. View

20.

Heiner D . IgG subclass composition of intravenous immunoglobulin preparations: clinical relevance. Rev Infect Dis. 1986; 8 Suppl 4:S391-5. DOI: 10.1093/clinids/8.supplement_4.s391. View